Growing Geriatric Population to Augment the Canes and Crutches Market Growth

 

Canes and Crutches Market Growth

Canes and crutches are assistive devices that help improve the quality of life of people living with disabilities, especially the geriatric population. Canes and crutches help an individual with walking disability or ambulation and even after surgery. These devices are widely used by the geriatric population as they are prone to diminishing activities because of various chronic diseases, accidents or leg injury, and frequent falls.

Canes have four components, such as ferrule, shaft, column, and handle. Canes are used as walking aid which helps redistribute the body weight, improve stability, and maintain balance. Whereas crutch transfers the weight from legs to the upper body. However, crutch can take more of the body weight than canes. Canes and crutches are used in cases of fracture, obesity, arthritis, developmental disabilities, walking impairment, balancing problems, and others.

Market Dynamics:

The growing demand for canes and crutches from the growing geriatric population worldwide is expected to propel the growth of the canes and crutches market. For instance, according to the World Health Organization (WHO), the world's population aged 60 years and older is expected to total 2 billion by 2050, up from 900 million in 2015.

Moreover, increasing research and development activities and approvals of novel designs from regulatory bodies are expected to drive the growth of the canes and crutches market. For instance, in 2018, Mobility Designed received the European Medical Agency approval for its canes and crutches. The novel crutch have hinged arm that allows free movement of hands which was not possible in conventional crutches.

However, the availability of alternatives for canes and crutches is expected to restrain the growth of the canes and crutches market. For instance, wheelchairs and knee walkers can be used in place of canes and crutches.

In December 2020, Tanzania Cigarette Public Limited Company (TCC plc.) donated more than 800 assistive devices, such as canes and crutches, to people living with disabilities under its community investment flagship program 'Together Creating Change.'

Competitive Analysis:

Major players operating in the canes and crutches market are Ossenberg GmbH, Medline Industries Inc., Besco Medical, Nova Medical Products, Mobility Designed LLC, Sunrise Medical, Cardinal Health, TFI HealthCare, Drive DeVilbiss Healthcare, and Home Medical Products Inc.

Major players in the market are increasingly focused on adopting various strategies such as business expansion, product launch, etc. to enhance their market position. For instance, in 2018, GF Health Products opened a new manufacturing facility in the United States to manufacture products such as crutches, canes, wheelchair, and other personal aids.

Comments

Post a Comment

Popular posts from this blog

The Emergence of COVID-19 to Augment Growth of the Outsourced Drug Discovery Market

Image
  With billions of dollars in research and development costs, pharmaceutical companies around the world are always looking for new ways to address their production processes in a cost-effective manner. One way to achieve this is through outsourcing drug discovery and development services. This type of service refers to the collaboration between small and large biotech and biotechnology companies to conduct research and development activities aimed at finding better solutions to the company's core chemical concerns. Outsourcing of these drug discovery services has enabled established pharmaceutical and biotechnology companies to focus on the development of new products that can bring about significant therapeutic change and provide tangible advantages to the company's shareholders. Contract research organizations manage almost all aspects of drug discovery. Market Dynamics I ncreasing demand for outsourcing analytical testing and clinical trial services, growing R&D ex...
Read more

Otoscope Market Is Gaining Major Traction with Industry Leader Otonexus Medical Technologies Introducing Ultrasound Sensor, Which Aids Middle-Ear Infection Diagnosis

Image
  An otoscope or auricular ear picker is a simple health care tool that is used to inspect the outer ear. Many health care professionals utilize otoscopes to examine ear infections during routine check-ups and to also screen for serious ear disorders. An otoscope possibly provides a more detailed view of the external ear canal and/or ear drum or eardrum. Otoscope or also referred to as auriscope is mainly used to look into eyes. The demand for these medical devices has been on a rise in the recent past. This is typically due to the fact that there is a high burden of ENT-related diseases across the globe. As per the World Health Organization (WHO), by 2050, around 2.5 billion people are estimated to have some degree of hearing loss worldwide. Similarly, there is a heavy burden of sinusitis cases. As per the Sinusitis & Allergy Wellness Center, around 30 million adults in the U.S. are impacted with sinusitis annually. Such a high prevalence of ENT disorders has accelerated the d...
Read more

The Number of Cancer Survivors Is Projected To Increase to 22.2 Million By 2030 Fostering Oncology Drug Pipeline Analysis Market

Image
  North America is estimated to dominate the global oncology drug pipeline analysis market in the near future and this is attributed to the high prevalence of cancer and increasing launch of various novel drugs with improved efficacy. According to the National Cancer Institute, as of January 2019, there were an estimated 16.9 million cancer survivors in the United States. The number of cancer survivors is projected to increase to 22.2 million by 2030. The oncology field is experiencing significant growth and this is attributed to the increasing development of various novel therapies for the treatment of cancer. For instance, in February 2021, Rhizen Pharmaceuticals AG, a clinical-stage, oncology-focused biopharma company, with a 50% stake owned by Alembic Pharmaceuticals and the rest by its Indian CEO Swaroop Vakkalanka, has announced that its the novel, next-generation PI3K-delta inhibitor Umbralisib (Ukoniq) has secured U.S. FDA accelerated approval for the treatment of blood c...
Read more